Compare TOWN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | RLAY |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | 2976 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | N/A | 2020 |
| Metric | TOWN | RLAY |
|---|---|---|
| Price | $35.94 | $12.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $17.44 |
| AVG Volume (30 Days) | 368.8K | ★ 3.2M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $35.63 | N/A |
| Revenue Next Year | $5.18 | $324.03 |
| P/E Ratio | $16.23 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $31.91 | $2.71 |
| 52 Week High | $37.86 | $17.32 |
| Indicator | TOWN | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 60.57 | 45.07 |
| Support Level | $34.69 | $6.67 |
| Resistance Level | $37.22 | $17.32 |
| Average True Range (ATR) | 0.83 | 1.08 |
| MACD | 0.01 | -0.33 |
| Stochastic Oscillator | 69.19 | 2.99 |
Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.